Diakard makes key acquisition in the creation of a global network of Diakard Centers of Excellence

DIAKARD, INC. a global provider of innovative diabetes treatments and solutions, today announced its acquisition of Pfützner Science and Health Institute, GmbH (PSHI), an internationally recognized developer and provider of therapeutics, diagnostics and clinical care in diabetes and related conditions. PSHI specializes in solutions that enhance the health and well-being of healthcare consumers through digital integration of their healthcare information, specific diagnostics and a customized treatment regimen for diabetes and cardiovascular disease. DIAKARD's treatment protocols are able to capture early pre-diabetes indicators and actively intersect the disease progression, in addition to the ability to deliver personalized treatments throughout all phases and into late-stage diabetes with secondary complications.
（以上内容由医药魔方AI生成）